|Prima Biomed Ltd -- USA Stock|| |
USD 0.012 0.002 20%
Member of the Clinical Advisory BoardWe currently do not have informatin regarding Bradley Monk. This executive tanure with Prima Biomed Ltd is not currenlty determined.
Executive Since 2014
61 2 8315 7003 http://www.primabiomed.com.au
The company has return on total asset (ROA)
of (15.25) %
which means that it has lost $15.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (30.29) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 4.4 M in total debt with debt to equity ratio (D/E) of 21.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Prima Biomed Ltd has Current Ratio of 5.93 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Prima BioMed Ltd. engages in the research, development, and commercialization of medical biotechnology solutions in Australia. Prima Biomed Ltd (PRRUF) is traded on OTC Market in USA. It is located in Sydney, NSW and employs 31 people.